Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

2.

Thrombolysis for acute ischaemic stroke.

Wardlaw JM, Zoppo G, Yamaguchi T, Berge E.

Cochrane Database Syst Rev. 2003;(3):CD000213. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD000213.

PMID:
12917889
3.

Clinical recovery and health-related quality of life in ischaemic stroke survivors receiving thrombolytic treatment: a 1-year follow-up study.

Grabowska-Fudala B, Jaracz K, Górna K, Jaracz J, Kaźmierski R.

J Thromb Thrombolysis. 2017 Jan;43(1):91-97. doi: 10.1007/s11239-016-1419-3.

PMID:
27613176
4.

Perceived wellbeing of patients one year post stroke in general practice--recommendations for quality aftercare.

de Weerd L, Rutgers WA, Groenier KH, van der Meer K.

BMC Neurol. 2011 Mar 31;11:42. doi: 10.1186/1471-2377-11-42.

5.

The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.

Rusanen H, Saarinen JT, Sillanpää N.

Cerebrovasc Dis. 2015;39(2):130-7. doi: 10.1159/000371339. Epub 2015 Jan 31.

PMID:
25660943
6.

Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.

Zaidat OO, Suarez JI, Santillan C, Sunshine JL, Tarr RW, Paras VH, Selman WR, Landis DM.

Stroke. 2002 Jul;33(7):1821-6.

7.

Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.

Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.

Cerebrovasc Dis. 2013;35(1):45-52. doi: 10.1159/000345071. Epub 2013 Feb 14.

PMID:
23428996
8.

Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy.

Jauss M, Schütz HJ, Tanislav C, Misselwitz B, Rosenow F.

Eur J Neurol. 2010 Apr;17(4):555-61. doi: 10.1111/j.1468-1331.2009.02845.x. Epub 2010 Feb 10.

PMID:
20218973
9.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

10.

Thrombolysis for acute ischaemic stroke.

Wardlaw JM, del Zoppo G, Yamaguchi T.

Cochrane Database Syst Rev. 2000;(2):CD000213. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD000213.

PMID:
10796329
11.

Acute stroke management in the elderly.

Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD.

Cerebrovasc Dis. 2007;23(4):304-8. Epub 2006 Dec 29.

PMID:
17199089
12.
13.

Quality of Life during the First Two Years Post Stroke: The Restore4Stroke Cohort Study.

van Mierlo ML, van Heugten CM, Post MW, Hajós TR, Kappelle LJ, Visser-Meily JM.

Cerebrovasc Dis. 2016;41(1-2):19-26. doi: 10.1159/000441197. Epub 2015 Nov 19.

PMID:
26580841
14.

Thrombolysis for acute ischaemic stroke.

Wardlaw JM, Murray V, Berge E, Del Zoppo GJ.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD000213. doi: 10.1002/14651858.CD000213.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD000213.

PMID:
19821269
15.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

16.

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

PMID:
21968092
17.

Determinants of quality of life in Brazilian stroke survivors.

Carod-Artal FJ, Trizotto DS, Coral LF, Moreira CM.

J Neurol Sci. 2009 Sep 15;284(1-2):63-8. doi: 10.1016/j.jns.2009.04.008. Epub 2009 May 2.

PMID:
19411080
18.

Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke.

You JS, Chung SP, Chung HS, Lee HS, Park JW, Kim HJ, Lee SH, Park I, Lee HS.

Am J Emerg Med. 2013 Dec;31(12):1699-702. doi: 10.1016/j.ajem.2013.08.029. Epub 2013 Sep 20.

PMID:
24055479
19.

Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.

Tu HT, Campbell BC, Christensen S, Desmond PM, De Silva DA, Parsons MW, Churilov L, Lansberg MG, Mlynash M, Olivot JM, Straka M, Bammer R, Albers GW, Donnan GA, Davis SM; EPITHET-DEFUSE Investigators.

Int J Stroke. 2015 Jun;10(4):534-40. doi: 10.1111/ijs.12007. Epub 2013 Mar 12.

20.

Functional recovery at 3 months in stroke patients not receiving thrombolytic therapy: the comparison between patients arriving earlier and later than 4.5 hours.

Duangjit S, Muangpaisan W, Chotinaiwattarakul W, Dharmasaroja P.

J Stroke Cerebrovasc Dis. 2014 Jan;23(1):91-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.003. Epub 2012 Nov 28.

PMID:
23200190

Supplemental Content

Support Center